<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04555863</url>
  </required_header>
  <id_info>
    <org_study_id>1798/2019</org_study_id>
    <nct_id>NCT04555863</nct_id>
  </id_info>
  <brief_title>haMSter: a Novel Smartphone Communication Tool for People With MS</brief_title>
  <official_title>haMSter: a Novel Smartphone Communication Tool for People With MS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs)&#xD;
      in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app&#xD;
      for 6 months and be asked to fill out the PRO questionnaires on their Smartphone.&#xD;
&#xD;
      Endpoints include the adherence to this app and satisfaction with this Intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Actual">June 1, 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>adherence to device</measure>
    <time_frame>over the course of this study (over 6 months)</time_frame>
    <description>Percentage (Number) of participants having completed all necessary questionnaires per study period. Max: 6 completions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall satisfaction with this application in telemedicine</measure>
    <time_frame>after study completion (after 6 months)</time_frame>
    <description>TMPQ (Telemedicine Perception Questionnaire). Min: 0 points. Max: 80 Points. Higher scores indicate a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General satisfaction with specific Features of the haMSter app</measure>
    <time_frame>after study completion (after 6 months)</time_frame>
    <description>Empirical questionnaires. We will Report frequencies of answers given. There is no Overall score in a larger sense.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>M-health</condition>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>haMSter app</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving the app for personal use for 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>haMSter smartphone app</intervention_name>
    <description>the app tracks patient reported outcomes</description>
    <arm_group_label>haMSter app</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any MS according to MacDonald criteria&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - language barriers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>September 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Patrick Altmann MD PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>m-health</keyword>
  <keyword>multiple sclerosis</keyword>
  <keyword>patient reported outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Individual participant data can only be shared after publication and upon reasonable request made to our local ethics review board.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

